KRMN enters July with a sharp week-on-week rebound masking a month of pain — and a fresh target cut from Citigroup dropping right as the stock tries to recover.
The price action tells a split story. KRMN closed Tuesday at $49.92, up nearly 8% on the week and 6% on the final session alone. Yet the stock remains down 13% over the past month, and the week's gains came against a backdrop of sector-wide underperformance — close peers KTOS, LHX, DRS, and BWXT all posted negative returns on the week, with DRS down 6.7% and BWXT off more than 7%. KRMN's bounce was an outlier, not a tide.
Short interest has drifted higher alongside that bounce — a tension worth noting. Bears have added modestly, with SI rising roughly 5.7% over the week to 6.8% of the free float, representing about 8.95 million shares. The rebuild follows a steady unwind through May, when SI was running closer to 9.5 million shares before trimming back in early June. Borrow conditions remain entirely comfortable: availability is at 370% — meaning there are roughly 3.7 shares available to lend for every one already borrowed — and cost to borrow is just 0.56%, a nominal fee. This is a market where new short positions face no friction whatsoever. The ORTEX short score has crept up to 53.7 from 51.1 two weeks ago, a quiet drift that mirrors the gradual short rebuild but falls well short of signalling crowding.
The Street's overall direction is constructive but visibly losing conviction. Citigroup's John Godyn — who had raised his target as recently as March — cut it again this week, moving from $97 to $76 while holding his Buy rating. That follows a wave of target reductions in mid-May: Keybanc trimmed from $122 to $100, Piper Sandler from $127 to $114, and Evercore ISI from $125 to $100. The consensus mean price target now sits at $103.50, more than double the current price — but the direction of travel on those targets has been one-way downward for two months. One lone Sell-rated analyst at BWS Financial holds a $37 target, a view that looks well outside the pack but has not changed. The bull case centres on Karman's $1 billion backlog, missile inventory replenishment demand, and the maritime defense acquisition that expanded addressable markets. The bear case is more prosaic: integration costs and margin pressure from the same acquisition are denting near-term profitability. The PE multiple has compressed nearly 30 points over the past month, landing at 60.7x — still not cheap, but moving in the direction of the bears. EV/EBITDA has eased to 26.5x on the same trend.
Institutional positioning adds a layer of interest. FMR (Fidelity) reported building its stake to 6.3% of shares as of end-April, adding over 2.5 million shares in the period. BlackRock added half a million shares through May. Vanguard and Columbia Management both initiated or substantially built positions in Q1. Against that accumulation, insider data is stale — the most recent trades on record are from December 2025, when CEO Anthony Koblinski sold 75,000 shares a week for four consecutive weeks at prices in the mid-to-upper $60s. Those sales now look timely in hindsight. The insider data cutoff at December 2025 means no visibility into whether that cadence continued into 2026.
The next earnings event is pencilled in for August 7. KRMN's only available earnings reaction data comes from May's Q1 print, when the stock surged 14.4% the following day and held most of that gain over the subsequent week. That was a strong beat-and-raise dynamic against a reset bar. The August print will arrive with the stock sitting roughly 20% below where it traded after that May reaction — and with analysts having spent the past six weeks trimming expectations. Whether Karman's integration costs have stabilised and whether backlog conversion has tracked guidance will be the numbers to watch.
See the live data behind this article on ORTEX.
Open KRMN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.